# Gilead Sciences, Inc. – FDA Inspection, Jul 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/a7c9d301-177d-4aa7-accc-64106381e6fa
Source feed: FDA_Inspections

> FDA inspection 1065316 of Gilead Sciences, Inc., July 17, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065316
- Company Name: Gilead Sciences, Inc.
- Inspection Date: 2018-07-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1300496 - 2026-01-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/d3db75e6-f2e4-4076-bd64-7e5ef2fd86dd)
- [FDA Inspection 1258330 - 2025-01-29](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/fe311bf5-631b-4491-9c5e-f31838502b8f)
- [FDA Inspection 1227801 - 2024-01-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/83ee39e1-a76c-424b-a9e1-f1575491e17e)
- FDA Inspection 1128174 - 2020-08-18
- [FDA Inspection 1125580 - 2020-07-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/7f61bbbc-bccb-4fea-97ef-3d2561b789f2)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/diane-c-van-leeuwen/98af0d70-2db1-4132-8193-fcccf8841960)
- [Company Rep](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)

Company: https://www.keypedia.com/companies/gilead-sciences-inc/05c4ed0b-5c05-4c0e-996e-9e344fef905c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c